BIO Conferences & Events

Published on Apr 23, 2013 David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and Moore, LLP discusses the Canadian Utility Requirement at the 2013 BIO International Convention.

At the 2013 BIO International Convention, Rachel King discusses how we can enhance the climate for innovation with communication, strong and helpful FDA, and need to protect financial incentives so we can deliver the innovations.

Winner, International BioGENEius Challenge at the 2013 BIO International Convention.

Keynote speaker Josh Sommer was recently named one of Forbes 30 Under 30 in Life Sciences and Healthcare. He discusses his rare cancer diagnosis while in college and his subsequent journey to become the Executive Director of The Chordoma Foundation. He also explains his search for information, insight and connections at the BIO International Convention.

Today, the 2013 U.S. National BioGENEius Challenge named the top 10 U.S. students finalists who will go on to compete in the next and final stage of the competition: the 2013 International BioGENEius Challenge on Tuesday.

Peer-reviewed article in Vaccine offers actions for bringing vaccines to 90% of the world.

Seth Ginsberg, President of the Global Healthy Living Foundation discusess their healthy biologics initiative to improve the quality of life for people with chronic illnesses at the 2013 BIO International Convention.

Jim Greenwood, the President and CEO of BIO, speaks about the exciting 2013 BIO International Convention. BIO is celebrating 20 years of the annual BIO International Convention, the largest biotech event in the world.